Nuclear receptors are receptor-superfamily drug targets considered for AI-based methods. They are described as more complex and challenging than data-rich enzyme targets, while offering potential for novel therapeutic use cases. section 8.1.1
Nuclear receptor
A nuclear receptor is an intracellular ligand-activated receptor that regulates DNA transcription and gene expression.
How Build AI Drug Discovery Pipelines covers it
- How deep it goes
- Names nuclear receptors as a target superfamily but does not explain their mechanism, pharmacology, or computational treatment.
- How it connects
- Connects nuclear receptors with GPCRs, ligand-gated ion channels, tyrosine kinase-linked receptors, kinases, and non-kinase enzymes.
This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.
